Back to search

Aristotle University Of Thessaloniki (AUTH)

Φαρμακοκινητικές αλληλεπιδράσεις φαρμάκων με φυτοθεραπευτικά σκευάσματα

Abstract

dc:description

Herbal medicinal products (HMPs) are trade products that consist of one or more phytochemical compounds or one or more plant materials. The HMPs are characterised and market distributed as dietary supplements or Complementary and Alternative Medicines (CAM). The concomitant use of HMPs and prescribed medications from patients is of wide concern in clinical practice, since their concurrent administration with drugs can affect the safety and efficacy profiles of prescribed medications. The aim of this study had been to investigate the potential and clinical significance of pharmacokinetic interactions of drugs with trade herbal preparations. The study focused on the efflux activity of P-glycoprotein (P-gp) which plays a significant role in the absorption and the metabolism of drugs mediated from cytochromes P-450 (CYPs). The effects of trade herbal preparations on P-gp function in Caco-2 cell monolayers were investigated by measuring the apparent permeability coefficient of Rhodamine-123. The metabolic activity mediated by recombinant CYPs was investigated by measuring the metabolism of probe drugs such as phenacetin through CYP1A2, S-warfarin through CYP2C9 and dextromethorphan through both CYP2D6 and CYP3A4. To this respect SIM GC/MS and HPLC/UV analytical methods were developed and validated in order to quantify the probe substrates and their metabolites. The in vitro observations were further estimated with the Simcyp® population-based pharmacokinetic simulator in an attempt to estimate the clinical significance of the in vitro data and lead to an in vivo study investigating the possible pharmacokinetic interactions with losartan a substrate of both P-gp and the cytochromes P-450 CYP2C9 and CYP3A4. The trade herbal products which were chosen to this study were Agnus castus, Aloe vera, Artichoke, Crocus sativus, Evening primrose oil, Ginseng, Guarana, Hawthorn, Hedera helix, Horse chestnut, Lobelia, Rhodiolarosea and Senna. The results from incubations with Caco-2 and recombinant CYPs showed that Rhodiola rosea, Artichoke, Agnus castus, Ginseng and Senna were found to be the most potent regarding the inhibition of P-gp and CYP-metabolism. The results from the Simcyp® revealed that Rhodiola rosea and Artichoke could be candidates for in vivo clinical studies. An in vivo pharmacokinetic study in rabbits regarding the interaction of losartan and Rhodiola rosea confirmed the estimation from the in vitro results and Simcyp® simulations.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Spanakis, Marios
  • Σπανάκης, Μάριος

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27628

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Spanakis, Marios; Σπανάκης, Μάριος. Φαρμακοκινητικές αλληλεπιδράσεις φαρμάκων με φυτοθεραπευτικά σκευάσματα. Aristotle University Of Thessaloniki (AUTH), 2012. http://hdl.handle.net/10442/hedi/27628